CD19-Targeted CAR-T Cells in Refractory Systemic Lupus Erythematosus: Safety, Efficacy, and Mechanistic Insights from the First Five Patients
Müller F, Völkl S, Mougiakakos D, Böltz S, Aigner M, Gary R, Kretschmann S, Kharboutli S, Kleyer A, Simon D, Rösler W, Habenicht KM, Winkler T, Krönke G, Schett G, Mackensen A (2022)
Publication Type: Conference contribution
Publication year: 2022
Journal
Publisher: AMER SOC HEMATOLOGY
City/Town: WASHINGTON
Pages Range: 4562-4563
Conference Proceedings Title: BLOOD
Event location: New Orleans, LA
DOI: 10.1182/blood-2022-165077
Authors with CRIS profile
Fabian Müller
Department of Medicine 5 – Haematology and Oncology
Simon Völkl
Department of Medicine 5 – Haematology and Oncology
Dimitrios Mougiakakos
Medizinische Fakultät
Sebastian Böltz
Department of Medicine 3 – Rheumatology and Immunology
Soraya Kharboutli
Medizinische Fakultät
Arnd Kleyer
Department of Medicine 3 – Rheumatology and Immunology
David Simon
Department of Medicine 3 – Rheumatology and Immunology
Wolf Rösler
Department of Medicine 5 – Haematology and Oncology
Katharina Marie Habenicht
Professur für Genetik
Thomas Winkler
Professur für Genetik
Gerhard Krönke
Department of Medicine 3 – Rheumatology and Immunology
Georg Schett
Lehrstuhl für Innere Medizin III
Andreas Mackensen
Lehrstuhl für Innere Medizin V
How to cite
APA:
Müller, F., Völkl, S., Mougiakakos, D., Böltz, S., Aigner, M., Gary, R.,... Mackensen, A. (2022). CD19-Targeted CAR-T Cells in Refractory Systemic Lupus Erythematosus: Safety, Efficacy, and Mechanistic Insights from the First Five Patients. In BLOOD (pp. 4562-4563). New Orleans, LA, US: WASHINGTON: AMER SOC HEMATOLOGY.
MLA:
Müller, Fabian, et al. "CD19-Targeted CAR-T Cells in Refractory Systemic Lupus Erythematosus: Safety, Efficacy, and Mechanistic Insights from the First Five Patients." Proceedings of the 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA WASHINGTON: AMER SOC HEMATOLOGY, 2022. 4562-4563.
BibTeX: Download